Abstract:Background: Kidney stones have become a common disease worldwide, and their incidence and recurrence rates have drastically increased over the past few decades. Oxalate decarboxylase (OxDC) enzyme which catalyzes the disproportionation reaction of oxalate monoanions into formate and CO2 could exhibit significant potential in the treatment of hyperoxaluria. Objective: The present work describes isolation and screening of new OxDC producing bacterial strain from oxalate-rich soils and one-factor-at-a-time (OFAT) and response surface methodology (RSM) statistical approaches were used to optimize the production media to obtain an improved intracellular OxDC production. Methods and Results: An OxDC producing bacterial strain, isolated from spinach soil sample(s), was identified to be Pseudomonas sp. OXDC12 by 16S rRNA sequencing. The OFAT approach was used to determine the effect of supplementation of carbon, nitrogen, and other physical conditions like pH, temperature, etc. on intracellular OxDC production by Pseudomonas sp. OXDC12. The three factors screened by Plackett Burman design (PBD) were further used by the central composite design (CCD) approach of RSM to determine their interactive effects on OxDC production. The anti-urolithiatic activity of the enzyme OxDC was determined by carrying out in vitro calcium oxalate crystallization in the presence and absence of OxDC. The factorial values selected by 23 CCD for OxDC were temperature 30oC, manganese ion concentration 5 mmol l-1, and inoculum size 3.25% (v/v). The highest predicted value of OxDC was 5.7 U ml-1 while the actual value obtained was 6.7 U ml-1 which was 79.1% and 2.92 fold greater than the initial activity of OxDC produced by Pseudomonas sp. OXDC12. As depicted by the light micrographs, OxDC displayed a significant reduction in the crystallization and formation of calcium oxalate stones as compared to the control under in vitro conditions. Conclusion: OFAT and RSM statistical optimization approaches led to improved OxDC production with a final activity of 6.7 U/mL and a 2.92 fold increase in the enzyme activity. The study suggests that OFAT and RSM optimization approaches significantly enhanced OxDC production from Pseudomonas sp. OXDC12. The enzyme may serve as a potential therapeutic agent for hyperoxaluria or kidney stones as it significantly inhibited the formation of calcium oxalate crystals under in vitro conditions.

Oxalogenesis in parenteral nutrition solution components

Parenteral Nutrition and Oxidant Load in Neonates

Analytical Methods for Oxalate Quantification: The Ubiquitous Organic Anion

Aluminum in Parenteral Nutrition Solution—Sources and Possible Alternatives

Nutritional profile and risk assessment of inorganic elements in enteral and parenteral nutrition formulas

Analysis of antibiotic stability in a parenteral nutrition solution

Effects Of Nitrogen Levels And Nitrate/Ammonium Ratios On Oxalate Concentrations Of Different Forms In Edible Parts Of Spinach

Aluminum and other chemical elements in parenteral nutrition components and all-in-one admixtures

Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products

Calcium and phosphorus conripatibility in parenteral nutrition solutions for neonates

Avoidance of Overt Precipitation and Patient Harm Following Errant Y‐Site Administration of Calcium Chloride and Parenteral Nutrition Compounded With Sodium Glycerophosphate

Bacterial/Fungal Growth in a Combined Parenteral Nutrition Solution

Evaluation of the Stability of Newborn Hospital Parenteral Nutrition Solutions

Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease

Stability of individualized neonatal parenteral nutrition admixtures with fish oil and high calcium content

Optimization of Growth Conditions for Oxalate Decarboxylase Production from Pseudomonas sp. OXDC12 and in vitro Inhibition of Calcium Oxalate Crystallization by Oxalate Decarboxylase

Development and Validation of a New Gas Chromatography–Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure

Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures

The all-in-one nutrient solution in parenteral nutrition

Oxidative Injury and Hepatocyte Apoptosis in Total Parenteral Nutrition-Associated Liver Dysfunction

Optimizing antigen preparation for oxalyl-CoA decarboxylase enzyme diagnostic kit and ELISA system cutoff determination